• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹部脂肪性水肿:通过拟议的诊断算法进行临床诊断与管理

Abdominal Lipedema: Clinical Diagnosis and Management Through a Proposed Diagnostic Algorithm.

作者信息

Bruno Agostino, Cilluffo Matteo

机构信息

Private Practice, Rome, Italy.

Plastic and Aesthetic surgery, University of Rome La Sapienza, Rome, Italy.

出版信息

Aesthetic Plast Surg. 2025 Sep 12. doi: 10.1007/s00266-025-05192-1.

DOI:10.1007/s00266-025-05192-1
PMID:40938408
Abstract

BACKGROUND

Lipedema is a chronic disorder of adipose tissue that predominantly affects women and is frequently misdiagnosed as obesity or lymphedema. Traditionally associated with the lower extremities, lipedema can also involve the abdominal region, although there are currently no established diagnostic criteria for abdominal lipedema. This study aims to propose a diagnostic algorithm for abdominal lipedema based on clinical features, macroscopic observations, and ultrasound findings.

METHODS

This retrospective study analyzed data from 327 patients treated between March 2018 and March 2024 for lipedema, including those with abdominal involvement. Clinical evaluations, ultrasound imaging, and surgical outcomes were examined to assess the prevalence and characteristics of abdominal lipedema. Patients were classified based on lipedema severity, and criteria for abdominal lipedema diagnosis were established through clinical and imaging data.

RESULTS

The study identified that abdominal involvement increases with the severity of lipedema, with 31% of patients with stage II lipedema and 70% of those with stage III lipedema exhibiting abdominal manifestations. The proposed diagnostic algorithm includes maximum, major, and minor criteria, such as symmetrical fat deposition, pain, and non-responsiveness to diet and exercise. Specific threshold values for each category were defined to establish the diagnosis. The findings highlight the existence of both ascending (from legs to abdomen) and descending (from arms to abdomen) centripetal progression patterns, challenging traditional notions that limit lipedema to the extremities CONCLUSION: Abdominal lipedema is a significant and underrecognized manifestation of the condition, requiring specific diagnostic criteria to ensure accurate diagnosis and appropriate treatment. The study proposes a diagnostic framework based on clinical and imaging features that can improve the recognition and management of abdominal lipedema. Multidisciplinary treatment approaches, including both conservative measures and surgical interventions such as abdominoplasty and liposuction, are recommended to improve patient outcomes.

LEVEL OF EVIDENCE IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

摘要

背景

脂肪性水肿是一种主要影响女性的慢性脂肪组织疾病,常被误诊为肥胖或淋巴水肿。传统上脂肪性水肿与下肢有关,也可累及腹部区域,尽管目前尚无腹部脂肪性水肿的确切诊断标准。本研究旨在基于临床特征、宏观观察和超声检查结果,提出一种腹部脂肪性水肿的诊断算法。

方法

这项回顾性研究分析了2018年3月至2024年3月间接受脂肪性水肿治疗的327例患者的数据,包括有腹部受累的患者。对临床评估、超声成像和手术结果进行检查,以评估腹部脂肪性水肿的患病率和特征。根据脂肪性水肿的严重程度对患者进行分类,并通过临床和影像数据建立腹部脂肪性水肿的诊断标准。

结果

研究发现,腹部受累情况随脂肪性水肿严重程度的增加而增加,II期脂肪性水肿患者中有31%、III期脂肪性水肿患者中有70%出现腹部表现。所提出的诊断算法包括主要、次要和微小标准,如对称性脂肪沉积、疼痛以及对饮食和运动无反应。为每个类别定义了特定的阈值以确立诊断。研究结果突出了向心性进展模式的存在,既有从腿部到腹部的上行模式,也有从手臂到腹部的下行模式,这对将脂肪性水肿局限于四肢的传统观念提出了挑战。结论:腹部脂肪性水肿是该疾病的一种重要但未得到充分认识的表现形式,需要特定的诊断标准以确保准确诊断和恰当治疗。该研究提出了一个基于临床和影像特征的诊断框架,可以提高对腹部脂肪性水肿的识别和管理。建议采用多学科治疗方法,包括保守措施以及腹部整形术和抽脂术等手术干预,以改善患者预后。

证据级别IV:本刊要求作者为每篇文章指定证据级别。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266 。

相似文献

1
Abdominal Lipedema: Clinical Diagnosis and Management Through a Proposed Diagnostic Algorithm.腹部脂肪性水肿:通过拟议的诊断算法进行临床诊断与管理
Aesthetic Plast Surg. 2025 Sep 12. doi: 10.1007/s00266-025-05192-1.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
4
Elbow Fractures Overview肘部骨折概述
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
7
Short-Term Memory Impairment短期记忆障碍
8
Post-pandemic planning for maternity care for local, regional, and national maternity systems across the four nations: a mixed-methods study.针对四个地区的地方、区域和国家孕产妇保健系统的疫情后规划:一项混合方法研究。
Health Soc Care Deliv Res. 2025 Sep;13(35):1-25. doi: 10.3310/HHTE6611.
9
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

本文引用的文献

1
National survey of patient symptoms and therapies among 707 women with a lipedema phenotype in the United States.美国 707 名脂肪营养不良表型女性患者的症状和治疗方法的全国性调查。
Vasc Med. 2024 Feb;29(1):36-41. doi: 10.1177/1358863X231202769. Epub 2023 Oct 16.
2
Modified Mediterranean-Ketogenic Diet and Carboxytherapy as Personalized Therapeutic Strategies in Lipedema: A Pilot Study.改良地中海生酮饮食和羧基疗法作为脂肪水肿的个性化治疗策略:一项初步研究。
Nutrients. 2023 Aug 20;15(16):3654. doi: 10.3390/nu15163654.
3
Mitochondrial DNA methylation in metabolic associated fatty liver disease.
代谢相关脂肪性肝病中的线粒体DNA甲基化
Front Nutr. 2023 May 25;10:964337. doi: 10.3389/fnut.2023.964337. eCollection 2023.
4
Lipedema: Insights into Morphology, Pathophysiology, and Challenges.脂肪性水肿:对形态学、病理生理学及挑战的见解
Biomedicines. 2022 Nov 30;10(12):3081. doi: 10.3390/biomedicines10123081.
5
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.脂肪组织中 PIK3CA 功能获得性突变诱导具有沃伯格样效应的代谢重编程和严重的内分泌紊乱。
Sci Adv. 2022 Dec 9;8(49):eade7823. doi: 10.1126/sciadv.ade7823.
6
Standard of care for lipedema in the United States.美国脂性水肿的护理标准。
Phlebology. 2021 Dec;36(10):779-796. doi: 10.1177/02683555211015887. Epub 2021 May 28.
7
Update in the management of lipedema.脂肪水肿的治疗进展。
Int Angiol. 2021 Aug;40(4):345-357. doi: 10.23736/S0392-9590.21.04604-6. Epub 2021 Apr 19.
8
Aldo-Keto Reductase 1C1 () as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema.醛酮还原酶 1C1()作为非综合征性原发性脂肪营养不良家族中的第一个突变基因。
Int J Mol Sci. 2020 Aug 29;21(17):6264. doi: 10.3390/ijms21176264.
9
Lipedema-Pathogenesis, Diagnosis, and Treatment Options.脂肪水肿-发病机制、诊断和治疗选择。
Dtsch Arztebl Int. 2020 Jun 1;117(22-23):396-403. doi: 10.3238/arztebl.2020.0396.
10
DNMT3a and TET2 in adipocyte insulin sensitivity.
Oncotarget. 2018 Oct 19;9(82):35289-35290. doi: 10.18632/oncotarget.26246.